Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell …

BR Balsara, G Sonoda, S Du Manoir, JM Siegfried… - Cancer research, 1997 - AACR
BR Balsara, G Sonoda, S Du Manoir, JM Siegfried, E Gabrielson, JR Testa
Cancer research, 1997AACR
Comparative genomic hybridization analysis was used to identify chromosomal imbalances
in 20 non-small cell lung carcinoma (NSCLC) biopsies and cell lines. The chromosome
arms most often overrepresented were 3q (85%), 5p (70%), 7p (65%), and 8q (65%), which
were observed at high copy numbers in many cases. Other common overrepresented sites
were 1q, 2p, and 20p. DNA sequence amplification was often observed, with the most
frequent site being 3q26 (six cases). Other recurrent sites of amplification included 8q24 …
Abstract
Comparative genomic hybridization analysis was used to identify chromosomal imbalances in 20 non-small cell lung carcinoma (NSCLC) biopsies and cell lines. The chromosome arms most often overrepresented were 3q (85%), 5p (70%), 7p (65%), and 8q (65%), which were observed at high copy numbers in many cases. Other common overrepresented sites were 1q, 2p, and 20p. DNA sequence amplification was often observed, with the most frequent site being 3q26 (six cases). Other recurrent sites of amplification included 8q24, 3q13, 3q28-qter, 7q11.2, 8p11–12, 12p12, and 19q13.1–13.2. The most frequent underrepresented segment was 3p21 (50%); other recurrent sites of autosomal loss included 8p21-pter, 15q11.2–13, 5q11.2–15, 9p, 13q12–14, 17p, and 18q21-qter. These regions of copy number decreases are also common sites of allelic loss, further implicating these sites as locations of tumor suppressor genes. Although some of the overrepresented segments harbor known or suspected oncogenes/growth-regulatory genes, we have identified 3q and 5p as new sites that are very frequently overrepresented in NSCLC. These findings could represent entry points for the identification of novel amplified DNA sequences that may contribute to the development or progression of NSCLC.
AACR